Solstice settles infringement claims against Beekly

A patent infringement lawsuit against medical product manufacturer Beekley, brought by radiological marker provider Solstice based in Portland, Maine, was dismissed with prejudice following a settlement agreement reached on Sept. 30 between the two parties.

Solstice filed the suit in 2009 alleging that Beekley’s mammography markers infringed the company’s patent for x-ray skin identification markers. Beekley denied infringement and counterclaimed infringement of its patent and trademark registration.
 
U.S. District Judge D. Brock Hornby of the District of Maine dismissed the claim in August, citing that Beekley’s products were used solely for mammography and did not infringe Solstice’s podiatry patents. The companies also dismissed with prejudice all claims and counterclaims, and the terms of the settlement agreement remain confidential, stated Bristol, Conn.-based Beekley.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.